Results Snapshot
Figures in Cr
Consolidate Annual Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Net Sales
2,762.90
2,461.40
2,226.60
2,016.90
2,087.40
1,581.30
1,330.40
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,762.90
2,461.40
2,226.60
2,016.90
2,087.40
1,581.30
1,330.40
Raw Material Cost
534.60
481.50
451.40
447.20
502.30
397.30
298.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
503.30
455.80
424.50
376.50
364.90
273.70
242.60
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
402.40
341.90
313.00
282.00
284.50
204.30
173.00
Other Expenses
540.10
486.70
428.40
421.30
375.00
269.70
272.50
Total Expenditure (Excl Depreciation)
1,980.40
1,765.90
1,617.30
1,527.00
1,526.70
1,145.00
986.80
Operating Profit (PBDIT) excl Other Income
782.50
695.50
609.30
489.90
560.70
436.30
343.60
Other Income
101.30
93.40
69.20
41.70
52.50
51.30
55.00
Operating Profit (PBDIT)
883.80
788.90
678.50
531.60
613.20
487.60
398.60
Interest
22.80
22.30
29.40
37.50
30.20
16.00
15.30
Exceptional Items
-30.10
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
830.90
766.60
649.10
494.10
583.00
471.60
383.30
Depreciation
161.80
141.90
143.60
150.20
108.10
77.20
72.80
Profit Before Tax
669.10
624.70
505.50
343.90
474.90
394.40
310.50
Tax
159.30
132.50
143.20
102.80
124.60
97.90
82.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
509.80
492.20
362.30
241.10
350.30
296.50
227.60
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
509.80
492.20
362.30
241.10
350.30
296.50
227.60
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-5.00
-5.10
-4.60
-2.20
-5.50
-4.90
-1.70
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
504.80
487.10
357.70
238.90
344.80
291.60
225.90
Equity Capital
167.60
83.60
83.50
83.40
83.30
83.30
83.30
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
2,340.60
2,089.10
1,765.80
1,582.90
1,424.70
1,161.70
949.50
Earnings per share (EPS)
30.12
29.13
42.84
28.65
41.39
35.01
27.12
Diluted Earnings per share
30.2
29.2
42.98
28.74
41.57
33.25
27.37
Operating Profit Margin (Excl OI)
28.32%
28.26%
27.36%
24.29%
26.86%
27.59%
25.83%
Gross Profit Margin
30.07%
31.14%
29.15%
24.5%
27.93%
29.82%
28.81%
PAT Margin
18.45%
20.0%
16.27%
11.95%
16.78%
18.75%
17.11%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2026 is 12.25% vs 10.55% in Mar 2025
Consolidate Net Profit
YoY Growth in year ended Mar 2026 is 3.63% vs 36.18% in Mar 2025
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2026 is 12.51% vs 14.15% in Mar 2025
Interest
YoY Growth in year ended Mar 2026 is 2.24% vs -24.15% in Mar 2025
Operating Profit Margin (Excl OI)
YoY Growth in year ended Mar 2026 has improved from Mar 2025
Compare Annual Results Of Dr Lal Pathlabs With
Figures in Cr
Consolidate Annual Results
Change(INR)
Change(%)
Net Sales
2,762.90
3,738.70
-975.80
-26.10%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,762.90
3,738.70
-975.80
-26.10%
Raw Material Cost
534.60
911.20
-376.60
-41.33%
Purchase of Finished goods
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
7.40
-7.40
-100.00%
Employee Cost
503.30
1,104.90
-601.60
-54.45%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
402.40
0.00
402.40
Other Expenses
540.10
-2,023.50
2,563.60
126.69%
Total Expenditure (Excl Depreciation)
1,980.40
0.00
1,980.40
Operating Profit (PBDIT) excl Other Income
782.50
3,738.70
-2,956.20
-79.07%
Other Income
101.30
0.00
101.30
Operating Profit (PBDIT)
883.80
0.00
883.80
Interest
22.80
48.80
-26.00
-53.28%
Exceptional Items
-30.10
-76.60
46.50
60.70%
Gross Profit (PBDT)
830.90
0.00
830.90
Depreciation
161.80
452.90
-291.10
-64.27%
Profit Before Tax
669.10
0.00
669.10
Tax
159.30
0.00
159.30
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
509.80
316.70
193.10
60.97%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
509.80
316.70
193.10
60.97%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
-5.00
0.00
-5.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
504.80
316.70
188.10
59.39%
Equity Capital
167.60
402.90
-235.30
-58.40%
Face Value
10.00
10.00
0.00
Reserves
2,340.60
4,436.20
-2,095.60
-47.24%
Earnings per share (EPS)
30.12
7.86
22.26
283.21%
Diluted Earnings per share
30.20
7.87
22.33
283.74%
Operating Profit Margin (Excl OI)
28.32%
0.00%
0.00
28.32%
Gross Profit Margin
30.07%
0.00%
0.00
30.07%
PAT Margin
18.45%
8.47%
0.00
9.98%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Annual - Net Sales
Net Sales 2,762.90 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.25% vs 10.55% in Mar 2025
Annual - Consolidate Net Profit
Consolidate Net Profit 504.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 3.63% vs 36.18% in Mar 2025
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 782.50 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 12.51% vs 14.15% in Mar 2025
Annual - Interest
Interest 22.80 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 2.24% vs -24.15% in Mar 2025
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 28.32%
in Mar 2026Figures in %
YoY Growth in year ended Mar 2026 has improved from Mar 2025






